Prospective, multi-centric, randomized, double-blind, two arm, parallel group, active control, comparative clinical study to evaluate efficacy and safety of R-TPR-021 / Humira in Patients with Active Rheumatoid Arthritis on a stable dose of Methotrexate.
Status: Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 17 Oct 2017
Price : $35 *
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Sponsors Reliance Life Sciences
- 09 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 12 May 2014 New trial record